Clinical Trial Update: Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating fast-acting naloxone nasal spray for gambling disorder and related opioid use conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gambling Disorder
• Opioid Use Disorder

Drugs mentioned

• Naloxone nasal spray (naloxone nasal spray)

Snippet

Sponsor: Finnish Institute for Health and Welfare | Conditions: Gambling, Opioid | Phase 2 | Status: COMPLETED